Does BRENTUXIMAB VEDOTIN Cause Interstitial lung disease? 74 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Interstitial lung disease have been filed in association with BRENTUXIMAB VEDOTIN (ADCETRIS). This represents 0.8% of all adverse event reports for BRENTUXIMAB VEDOTIN.
74
Reports of Interstitial lung disease with BRENTUXIMAB VEDOTIN
0.8%
of all BRENTUXIMAB VEDOTIN reports
18
Deaths
34
Hospitalizations
How Dangerous Is Interstitial lung disease From BRENTUXIMAB VEDOTIN?
Of the 74 reports, 18 (24.3%) resulted in death, 34 (45.9%) required hospitalization, and 3 (4.1%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for BRENTUXIMAB VEDOTIN.
What Other Side Effects Does BRENTUXIMAB VEDOTIN Cause?
Off label use (1,370)
Neuropathy peripheral (695)
Pyrexia (693)
Febrile neutropenia (684)
Death (602)
Neutropenia (561)
Hodgkin's disease (512)
Nausea (392)
Diarrhoea (385)
Anaemia (374)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which BRENTUXIMAB VEDOTIN Alternatives Have Lower Interstitial lung disease Risk?
BRENTUXIMAB VEDOTIN vs BREO ELLIPTA
BRENTUXIMAB VEDOTIN vs BREXANOLONE
BRENTUXIMAB VEDOTIN vs BREXPIPRAZOLE
BRENTUXIMAB VEDOTIN vs BREXUCABTAGENE AUTOLEUCEL
BRENTUXIMAB VEDOTIN vs BRIGATINIB